Bones and joints infections
By
Solomon Weldegebreal(B.pharm, Msc)
Bones and joints infections
• Osteomyelitis
• Prosthetic Joint Infections,
• Diabetic Foot Infections, and Septic Arthritis
Introduction
• Infection of the bone with subsequent bone
destruction
• Around 20 cases per 100,000 population
• The epidemiology of osteomyelitis has been
changing over the past several decades
The incidence of acute hematogenous
osteomyelitis, which is most often seen in children,
has been declining
• the frequency of contiguous osteomyelitis has been
increasing
- PVD, DM, Trauma, prosthetic implants and surgical
interventions
Pathophysiology
• Healthy bone tissue is normally resistant to
infection but may become susceptible under
certain condition
• Bone can become infected via:
via the presence of bacteria in the
bloodstream,
by direct inoculation from trauma or surgery,
and
by spread from an adjacent site (e.g., soft-
tissue infection).
Pathogenesis
Characteristics of Osteomyelitis
Clinical presentation
• Hematogenous the patient typically
experiences systemic and localized signs and
symptoms
• In comparison, patients with chronic infection
typically present with only localized signs and
symptoms.
• Common signs and symptoms of osteomyelitis
include:
Systemic: Fever, chills, malaise
Localized: Pain or tenderness, edema, erythema,
inflammation, decreased range of motion of infected
area
Diagnosis
• The diagnosis of osteomyelitis is based on clinical
findings, laboratory tests, and imaging studies
• The gold standard for diagnosis is a bone biopsy
with isolation of microorganism(s) from culture and
the presence of inflammatory cells and
osteonecrosis on histological exam
o Due to the invasive nature of this procedure, imaging studies
and laboratory tests are generally used in making diagnose.
Diagnosis
• Non-specific inflammatory markers for infection
include
WBC, ESR, and CRP may be elevated or within normal
limits.
 An elevated WBC is mostly seen in patients with a cute
osteomyelitis. CRP rises faster than ESR during early
stages of infection.
 CRP returns to normal levels more quickly than ESR.
Treatment
Desired Outcomes
The treatment goals for osteomyelitis are to
eradicate the infection and prevent
recurrence. Cure rates of greater than 85%
have been reported for acute
hematogenous osteomyelitis.
In contrast, chronic osteomyelitis is
associated with higher failure rates largely
due to the presence of necrotic bone
General approach to treatment
• Antimicrobial therapy alone is the mainstay of
treatment for acute osteomyelitis.
• In comparison, treatment for chronic osteomyelitis
typically requires a combination of antimicrobial
therapy and surgical intervention
• If the patient is not a candidate for surgical
intervention, prolonged antimicrobial therapy is
generally necessary
Pharmacologic treatment
• Empiric antimicrobial therapy should target likely
causative pathogen(s) based on patient-specific risk
factors and route of infection
• Empiric antimicrobial coverage against S. aureus should
be considered for all classifications of osteomyelitis.
• Specific recommendations may vary based on factors
such as patient allergies, potential for harboring a
resistant organism, institution formulary, and cost
considerations
Pharmacologic treatment
• Typically, treatment is initiated with intravenous
• antimicrobials to ensure that therapeutic drug
concentrations will be achieved in the bone
• Intravenous therapy can be administered in the
inpatient or outpatient setting
• Following 1 to 2 weeks of intravenous therapy, a switch
to oral antibiotics may be considered in patients with
good adherence and outpatient follow-up
Pharmacologic Therapy
Pathogen-Targeted Antimicrobial Therapy and Dosing Recommendations in Pediatrics
and Adults
Selective toxicity and drug interactions associated with
antimicrobials
Patient Case
• W.A. is a 55-year-old man who presents with weight loss, malaise, and
severe back pain and spasms that have progressed during the past 2
months. He has also experienced loss of sensation in his lower extremities.
Four months before this admission, he had surgery for a fractured tibia,
followed by an infection treated with unknown antibiotics. W.A. has
hypertension and diverticulitis. On physical examination, he is alert and
oriented, with the following vital signs: temperature 99.4°F (37.4°C); heart
rate 88 beats/minute; respiratory rate 14 breaths/minute; and blood
pressure 130/85 mm Hg. His laboratory values are within normal limits,
except for WBC 14,300, erythrocyte sedimentation rate 89 mm/hour, and C-
reactive protein 12 mg/ dL. Magnetic resonance imaging shows bony
destruction of lumbar vertebrae 1 and 2, which is confirmed by a bone scan.
A computed tomography–guided bone biopsy shows gram-positive cocci in
clusters. Which one of the following is the best initial therapy for W.A.?
A. Vancomycin 15 mg/kg intravenously every 12 hours—duration of antibiotics:
6 weeks.
B. Nafcillin 2 g intravenously every 6 hours—duration of antibiotics: 2 weeks.
C. Levofloxacin 750 mg/day orally—duration of antibiotics: 6 weeks.
D. Ampicillin/sulbactam 3 g intravenously every 6 hours—duration of
antibiotics: 2 weeks.
Thank you

10. Bones and joints infections.pptx

  • 1.
    Bones and jointsinfections By Solomon Weldegebreal(B.pharm, Msc)
  • 2.
    Bones and jointsinfections • Osteomyelitis • Prosthetic Joint Infections, • Diabetic Foot Infections, and Septic Arthritis
  • 3.
    Introduction • Infection ofthe bone with subsequent bone destruction • Around 20 cases per 100,000 population • The epidemiology of osteomyelitis has been changing over the past several decades The incidence of acute hematogenous osteomyelitis, which is most often seen in children, has been declining • the frequency of contiguous osteomyelitis has been increasing - PVD, DM, Trauma, prosthetic implants and surgical interventions
  • 5.
    Pathophysiology • Healthy bonetissue is normally resistant to infection but may become susceptible under certain condition • Bone can become infected via: via the presence of bacteria in the bloodstream, by direct inoculation from trauma or surgery, and by spread from an adjacent site (e.g., soft- tissue infection).
  • 7.
  • 11.
  • 12.
    Clinical presentation • Hematogenousthe patient typically experiences systemic and localized signs and symptoms • In comparison, patients with chronic infection typically present with only localized signs and symptoms. • Common signs and symptoms of osteomyelitis include: Systemic: Fever, chills, malaise Localized: Pain or tenderness, edema, erythema, inflammation, decreased range of motion of infected area
  • 13.
    Diagnosis • The diagnosisof osteomyelitis is based on clinical findings, laboratory tests, and imaging studies • The gold standard for diagnosis is a bone biopsy with isolation of microorganism(s) from culture and the presence of inflammatory cells and osteonecrosis on histological exam o Due to the invasive nature of this procedure, imaging studies and laboratory tests are generally used in making diagnose.
  • 14.
    Diagnosis • Non-specific inflammatorymarkers for infection include WBC, ESR, and CRP may be elevated or within normal limits.  An elevated WBC is mostly seen in patients with a cute osteomyelitis. CRP rises faster than ESR during early stages of infection.  CRP returns to normal levels more quickly than ESR.
  • 16.
    Treatment Desired Outcomes The treatmentgoals for osteomyelitis are to eradicate the infection and prevent recurrence. Cure rates of greater than 85% have been reported for acute hematogenous osteomyelitis. In contrast, chronic osteomyelitis is associated with higher failure rates largely due to the presence of necrotic bone
  • 17.
    General approach totreatment • Antimicrobial therapy alone is the mainstay of treatment for acute osteomyelitis. • In comparison, treatment for chronic osteomyelitis typically requires a combination of antimicrobial therapy and surgical intervention • If the patient is not a candidate for surgical intervention, prolonged antimicrobial therapy is generally necessary
  • 18.
    Pharmacologic treatment • Empiricantimicrobial therapy should target likely causative pathogen(s) based on patient-specific risk factors and route of infection • Empiric antimicrobial coverage against S. aureus should be considered for all classifications of osteomyelitis. • Specific recommendations may vary based on factors such as patient allergies, potential for harboring a resistant organism, institution formulary, and cost considerations
  • 19.
    Pharmacologic treatment • Typically,treatment is initiated with intravenous • antimicrobials to ensure that therapeutic drug concentrations will be achieved in the bone • Intravenous therapy can be administered in the inpatient or outpatient setting • Following 1 to 2 weeks of intravenous therapy, a switch to oral antibiotics may be considered in patients with good adherence and outpatient follow-up
  • 20.
  • 21.
    Pathogen-Targeted Antimicrobial Therapyand Dosing Recommendations in Pediatrics and Adults
  • 24.
    Selective toxicity anddrug interactions associated with antimicrobials
  • 28.
    Patient Case • W.A.is a 55-year-old man who presents with weight loss, malaise, and severe back pain and spasms that have progressed during the past 2 months. He has also experienced loss of sensation in his lower extremities. Four months before this admission, he had surgery for a fractured tibia, followed by an infection treated with unknown antibiotics. W.A. has hypertension and diverticulitis. On physical examination, he is alert and oriented, with the following vital signs: temperature 99.4°F (37.4°C); heart rate 88 beats/minute; respiratory rate 14 breaths/minute; and blood pressure 130/85 mm Hg. His laboratory values are within normal limits, except for WBC 14,300, erythrocyte sedimentation rate 89 mm/hour, and C- reactive protein 12 mg/ dL. Magnetic resonance imaging shows bony destruction of lumbar vertebrae 1 and 2, which is confirmed by a bone scan. A computed tomography–guided bone biopsy shows gram-positive cocci in clusters. Which one of the following is the best initial therapy for W.A.? A. Vancomycin 15 mg/kg intravenously every 12 hours—duration of antibiotics: 6 weeks. B. Nafcillin 2 g intravenously every 6 hours—duration of antibiotics: 2 weeks. C. Levofloxacin 750 mg/day orally—duration of antibiotics: 6 weeks. D. Ampicillin/sulbactam 3 g intravenously every 6 hours—duration of antibiotics: 2 weeks.
  • 29.